Home / Campus Life & Events / Campus Announcements / Caltech Longevity Club Presents "The frontiers of genetic medicine - from biohacking to the clinic"

Caltech Longevity Club Presents "The frontiers of genetic medicine - from biohacking to the clinic"

April 18, 2025

Caltech Longevity Club

Speaker Spotlight: Matt Scholtz

Event registration link (By RSVP only) https://lu.ma/cicl1io3

Founder and Chief Executive Officer at Oisín Biotechnologies

Join us for an insightful session with Matthew Scholz, a visionary serial entrepreneur at the intersection of biotech and innovation. With a background in computer security, immunology, and gene therapy, Matt is the Founder and CEO of Oisín Biotechnologies, a company pioneering gene-targeted therapies to eliminate unwanted cells and one of the top 10 longevity companies in the world as of January 2025.

He also leads OncoSenX, an oncology-focused spin-out of Oisín, driving new frontiers in cancer treatment.

Previously, Matt founded Immusoft in 2009, where he served as CEO until 2017. He remains an active board member, supporting the company's mission to program patients' B cells to produce therapeutic proteins.

This session promises a fascinating look at the future of longevity and cell-based therapies from one of the field's most inventive minds.

For more events at the Caltech Longevity Club

Website: https://caltechlongevity.com/

Instagram: https://www.instagram.com/caltechlongevity/

Form to become a member: https://atom-meteoroid-b7d.notion.site/12e33e38a36f808c80dcd1ddd0a1d2d9